More than 400 Xarelto lawsuits are currently pending against Janssen Pharmaceuticals and Bayer Healthcare, alleging that the companies failed to disclose risks of severe side effects of Xarelto, […]
Lawsuits involving Janssen’s Xarelto medication continue to move forward. According to court records, 100 Xarelto lawsuits have been filed since March 16, 2015 in the Xarelto multidistrict litigation […]
As more Xarelto lawsuits continue to be filed alleging severe bleeding complications, the U.S. District Judge overseeing the litigation has approved the direct filing of new cases in […]
In the last five months of 2013, drug makers spent nearly $20 million to promote medications hospitals and healthcare providers. Among the top 20 drugs listed by Business Insider that companies pay […]
The judge overseeing the federal Xarelto litigation will meet to discuss the process of moving the litigation forward at a status conference. The U.S. Judicial Panel on Multidistrict […]
Bloomberg Business reports that Johnson & Johnson and Bayer AG are fighting requests to consolidate lawsuit claims that Xarelto, a blood-thinning medication, caused patients to bleed to death. Patients who are […]
On January 22, 2015, a woman filed a lawsuit against the manufacturers of Xarelto, Bayer Healthcare Pharmaceuticals and Janssen Research and Development. The woman claims that during clinical trials […]
Xarelto lawsuit attorneys note with particular interest a study published in the prestigious Journal of the American Medical Association (JAMA) claiming that clinical trials for certain medications, including […]
The U.S. District Judge responsible for overseeing the recently established federal multidistrict litigation (MDL) for all federally-filed Xarelto lawsuits has scheduled an initial status conference to take place […]
When Xarelto and other newer blood thinners were released to the public, they were touted as a better solution to prevent blood clots than Coumadin, also known as warfarin, […]
A recent study published in the Canadian Journal of Cardiology has called into question Xarelto safety over Warfarin, both blood-thinners used in patients who suffer from atrial fibrillation. For […]
The bad drug list has been in existence for years, often because big pharmaceutical companies push the use of blockbuster drugs to healthcare practitioners. Blockbuster drugs are those […]
Xarelto, a blood thinner that is prescribed to certain patients for its anticoagulant properties, is supposed to safeguard against blood clots. The Food and Drug Administration (FDA) approved […]
In what appears to be a rush by the pharmaceutical companies to push new medications to market, problems with many of those medications are becoming more common. The […]
Bayer Announces New Xarelto Trials According to Reuters, the German pharmaceutical company Bayer recently announced that it is making plans to launch three Xarelto trials on additional uses […]